Trial intelligence / Profile preview

Intravitreal microplasmin for vitreomacular traction syndrome

2009-015516-18Phase 2Completed

Sponsor: Medical University of Vienna
Start: Jun 2010
Modality: Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries: 1

Overview

Phase 2, open-label, single-arm trial of ocriplasmin in vitreomacular traction (VMT), sponsored by Medical University of Vienna. Primary endpoints: Macular microstructural change by OCT, Best corrected visual acuity and 2 more. Started Jun 2010; status: completed.

Drugs

ocriplasmin

Conditions

vitreomacular traction (VMT)

Beyond the preview

Go deeper on 2009-015516-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015516-18.